Increased and normalized uptake of 18F-FDG in a case of bone periprosthetic infection treated by antibiotics

Hell J Nucl Med. 2017 May-Aug;20(2):176-178. doi: 10.1967/s002449910561. Epub 2017 Jul 12.

Abstract

We report the case of a 69 years old man with left hip prosthesis, who presented clinical, biochemical and imaging signs of periprosthetic infection treated with linezolid, an antibacterial agent of the oxazolidinone class. Two weeks after this treatment, a fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) scan showed increased uptake in the skeleton and also increased uptake in several focal areas in the spine and near the prosthesis and the surgical wound on the left gluteus medius. Bone marrow biopsy was negative; meanwhile the antibiotic therapy, after four weeks of treatment was stopped due to red blood cells and platelets toxicity. Six weeks later, the patient developed high fever again and in order to revaluate the periprosthetic inflammation, he was resubmitted to 18F-FDG PET/CT which showed normal 18F-FDG uptake in the whole skeleton, including the prosthesis and the subcutaneous wound. Some focal areas of increased uptake in the lumbar spine were still detected. In the next 4 weeks the patient was under a "watch and wait" follow-up in a steady state.

In conclusion: In the case we report, since we found no otnt focal areas in the lumbar spine where due to age-related bone deformities including some Schmorl's nodes. The inflammation in the bone prosthesis and the subcutaneous wound responded almost totally to the antibiotic treatment we applied.

Publication types

  • Case Reports

MeSH terms

  • Artifacts
  • Bone Diseases, Infectious / diagnostic imaging*
  • Bone Diseases, Infectious / drug therapy*
  • Bone Diseases, Infectious / etiology*
  • Diagnosis, Differential
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Hip Prosthesis / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / metabolism
  • Radiopharmaceuticals / pharmacokinetics
  • Spondylitis / diagnostic imaging
  • Spondylitis / etiology
  • Spondylitis / metabolism
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18